/Companies

CVRx

1 known investors

Find your way into CVRx

Sign up to see every warm intro you have to CVRx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CVRx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CVRx develops Barostim, an implantable neuromodulation therapy for heart failure patients that stimulates the body's natural baroreceptors to help the brain regulate heart function and relieve heart failure symptoms. Unlike a pacemaker or defibrillator, it is positioned as a device therapy shown to improve exercise capacity, quality of life, and functional status.

Investors · 1

Frequently asked questions

What does CVRx do?
CVRx develops Barostim, an implantable neuromodulation therapy for heart failure patients that stimulates the body's natural baroreceptors to help the brain regulate heart function and relieve heart failure symptoms. Unlike a pacemaker or defibrillator, it is positioned as a device therapy shown to improve exercise capacity, quality of life, and functional status.
Who are CVRx's investors?
CVRx's investors include Gilde Healthcare.